- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Empagliflozin with linagliptin – November 2017
Empagliflozin with linagliptin: Tablet containing 10 mg empagliflozin with 5 mg linagliptin, Tablet
Last updated
2 March 2018